I'm an exhibitor I'm a delegate Contact ACCP

 

Speakers and their topics
 

More speakers and their topics to be announced soon!

 


Keynote speaker

Anders Sorman-Nilsson

About:

  • Global Executive MBA (USYD)
  • Bachelor of Law Honours (ANU)
  • Bachelor of Arts (ANU)
  • Graduate Diploma of Legal Practice (ANU)

Managing Director and Founder of Thinque Anders is a reformed lawyer, an avid social commentator, and a somewhat funky thinker. He is the Creative Director and founder of the consultancy Thinque. Swedish by design, Germanic by schooling, and Australian by choice, he is a linguistic gymnast who challenges his audiences to upgrade the way they think.

A self-described cultural transvestite, Anders draws on a smorgasbord of international ideas and trends to inspire ideas and facilitate conversations. Anders is an expert on generational trends, thought leadership branding, and innovation. He is the author of 'Thinque Funky: Upgrade Your Thinking' (2009), 'Future Thinking: a trend-spotting report' (2008), the 'Gen Y 2.0 Limegreen Paper: from awareness to funky solutions' (2007) and creator of the podcast series 'Thinque's Espresso Shot'.

His keynotes, Thinque Tanks and consulting provide GPS directions for individual and organisational brands that want to successfully navigate a constantly changing business landscape and successfully position their intellectual property in a whacky world.

He works with an innovative portfolio of brands including Dow Jones and Fortune 500 companies, and some of the leading organisations on BusinessWeek Interbrand's Best Global Brands Ranking.

When he is not travelling or working, Anders likes to upgrade his own male thinking in the kitchen by attempting to cook multiple dishes at once, contemplating the merits of compulsory siestas, and potty-training his 3-year old kitten, Finnegan.

Blog: www.thinque.com.au/blog

 

Topic: Waves of change – global trends that will disrupt your existence

Waves of change are rolling towards the pharmaceutical industry and you’d better be prepared.

  • But how do you spot the waves, or identify what’s going on in the market?
  • How do you sense the direction of the currents, or establish what they mean for your business?
  • And how do you best position yourself so you’re not washed away, or choose a market position and ride the wave?  

Will you surf to success or drown in a riptide on an unpatrolled beach, while swimming outside the flags?  

Unfortunately for business leaders today, change doesn’t care whether you like it or not. In the pharmaceutical industry change happens ceaselessly without your permission.

The waves of change threatening every business are:

  1. Digital Disruption – managing the tension between the analogue and digital customer touch points
  2. Media Madness – realising that every company must think like a media company
  3. Data Driven Dominance – working out how to turn data into competitive knowledge

The ignorant and apathetic are swamped and go belly-up, but those that know how to recognise opportunity, innovate and welcome change will soar. Plus they’ll enjoy every moment of the journey.

Check Yourself

  • How aware are your leaders around which customer touch points should be digitised and which must be left alone?
  • Do your teams know how to use traditional and non-traditional media to actively engage with hyper critical customers, talent and prospects?
  • Does your organisation mine the data you are currently collecting about your customers and turning it into a strategic asset?
  • Does your organisation’s offering actually matter in today’s market and, more importantly, will it truly matter tomorrow? 

What’s in it for me – what will you learn?

  1. Which new markets you should target, and how to identify and engage them
  2. How to utilise specific forms of new media in order to communicate powerfully and engage audiences
  3. How to step back and deconstruct your own business model to identify new, non-traditional partnerships
  4. How to sort through the data storm to turn customer insight into intelligent and strategic business assets
  5. How to build innovation strategy that disrupts your competitors

 

 

International speaker

Jerrod Roberts (visiting us from USA)

About:


Jerrod Roberts, DPh is the owner and pharmacist-in-charge of Flourish Integrative Pharmacy in Oklahoma City, Oklahoma.  Jerrod graduated from the Southwestern Oklahoma State University School of Pharmacy in December of 1990.  Flourish Integrative Pharmacy is a Pharmacy Compounding Accreditation Board (PCAB) accredited facility that compounds both sterile and non-sterile preparations.

Jerrod was the 2007 President for the International Academy of Compounding Pharmacists (IACP) and has served on several committees including serving as a state leader, member of the Potency Task Force, IACP Accreditation Committee, IACP Treasurer and the IACP Executive Committee.  Additionally he has been the chair for the PCAB Standards committee.  Jerrod has published several articles in the International Journal of Pharmaceutical compounding and has co-authored the book APhA Accreditation Handbook, released in 2007.

For a complete curriculum vitae please contact Flourish Integrative Pharmacy at 405-751-3333.

 

Topic 1: Compounding for pain

This session is designed to discuss compounded prescription options to address pain.  These will include utilizing unique routes of administration, to include oral as well as topical treatment options.  Different medications will be discussed based on research articles as well as their intended mechanism of actions.  Additionally, we will discuss the process of educating the prescriber and patient to these treatment options. 

 

Topic 2: Nutritional care and testing

This session will be focused on the current and future trends in nutritional care, as currently seen in the US.  We will focus on different testing offerings within the pharmacy industry to aid in determining a treatment plan for an individual’s needs as well as the supplements being utilized in a pharmacy practice.  In addition, a comparison of the quality assurance for supplement suppliers and the potential impact on outcomes.

 

 

International speaker

Diego Marro (visiting us from Spain)

About:


Diego is the executive Vice-President of The International Society of Pharmaceutical Compounding (ISPhC). He is also the Director of Master in Pharmaceutical Care and Pharmacotherapy at the Faculty of Health Sciences, University of San Jorge, Zaragoza, Spain.

 

Topic 1: Pharmacists communicating with doctors / educating doctors

Abstract to be added shortly.

 

Topic 2: New innovative ideas – what’s happening in the world in compounding

Abstract to be added shortly.

 

 

International speaker

Shara Rudner

About:


EDUCATION and CURRENT CERTIFICATIONS | Ms. Rudner holds a BS in Pharmacy from the University of Rhode Island, College of Pharmacy. President of Belvidere Pharmacy since 1996, she oversees all operations and acts as the principle practitioner liaison. She is a fellow of the International Academy of Compounding Pharmacists (IACP), the American College of Apothecaries (ACA), and the American College of Veterinary Pharmacists (ACVP).

APPOINTMENTS | Ms. Rudner currently serves on the PCAB Accreditation Committee; as the President of the IACP Foundation (2012-2014); as secretary of the NJ Pharmacists Association Academy of Compounding Pharmacists; and as the Regional Director of the ACA (2003-2011).

TEACHING CREDENTIALS | Ms. Rudner is part of the adjunct faculty and /or preceptor for Rutgers University, Ernest Mario College of Pharmacy, Long Island University, College of Pharmacy, Everest Institute, and Sanford Brown Institute.
AWARDS and RECOGNITIONS | Professional Compounding Centers of America's (PCCA) Pharmacist of the Month, January 2001; ACVP's Earl W. "Bill" Bradley Award for Outstanding Service to Veterinary Pharmacy 2008; Belvidere Pharmacy, PCAB Accredited Compounding Pharmacy, March 2007-present; NJ Pharmacists Association's 2010 Excellence In Innovative Pharmacy Practice Award, November 2010.

PRESENTATIONS | PCCA International Seminar, Houston, TX, January 2000; PCCA International Seminar Houston, TX, January, 2001; NCPA Annual Conference, Boston, MA, October, 2004; ACA Midyear Conference, Tulsa, OK, April, 2006; IACP Annual Conference, Washington, DC, June, 2007; ACA Annual Conference, Savannah, GA, September, 2008; Ernest Mario College of Pharmacy Drug Delivery Lab, April 9, 2010; and "Beneath The Surface: Compounding's Practical and Unique Solutions", Dermaceutics Graduate Course presentation, Rutgers University February 25, 2012.

Topic 1: New technology in compounding

Abstract to be added shortly.

 

Topic 2: Innovative marketing

Abstract to be added shortly.

 

 

The Compounding Pharmacy Australia

Valentina Karan

About:


Valentina Karan is a compounding pharmacist and laboratory manager at The Compounding Pharmacy Australia based in Mosman, Sydney. She graduated from Faculty of Pharmacy, Belgrade, Serbia in 2004 and has obtained a Postgraduate Diploma in Cosmetic Science in 2010. Valentina's dominant area of interest is development of personalised approaches to skin care and skin disease treatments. Her professional engagements also include working in bioinformatics in toxicology and pathway modelling.

Topic: Cosmeceuticals in the compounding arena

The main goal is sharing information about cosmeceuticals that compounding pharmacists can utilise and implement in their everyday practice. Topics that will be covered include legislation, cosmetic ingredients and formulations and market opportunities for the compounding pharmacy in the world of pharmaceutical and cosmetic industry.

With growing customer awareness and concerns about cosmetic ingredients many pharmacists may find that their knowledge base is not always sufficient to give appropriate answers. Traditionally, enrolment in the pharmacy profession and cosmetic industry was kept separate. As a result pharmacists did not have the opportunity to learn about cosmetics and cosmetic chemists don't know much about medications. However, as the science goes deeper into revealing molecular mechanisms of action of conditions and diseases and how certain substances affect these processes, current definitions of medicine and cosmetics are challenged daily. This phenomenon led to the creation of the word – cosmeceuticals – products that are regarded as cosmetics that provide medical or drug-like benefits. During this talk explanation about pros and cons for this terminology will be presented, as well as the pharmacists' role, responsibilities and compounding opportunities.

Learning objectives:

  • Expanding knowledge base pharmacists have about cosmetics and formulations
  • Opportunities and limitations of formulating cosmetic products in compounding pharmacy
  • How to improve customer care by applying knowledge about cosmetics

 

 

Kenelec Scientific, Australia

Jason Kelly

About:


Cleanroom Monitoring Specialist-Kenelec Scientific.

Graduated from ITT Dublin Ireland in 1996. Started working at Intel Ireland as a Customer Engineer in Class 10 semiconductor cleanrooms manufacturing Pentiums. Moved to Sartorius Ireland as Service Manager in 1998 where he moved into the Pharmaceutical
Industry working on large Environmental Monitoring, Filtration and Fermentation Projects.

He was formally Managing Director of Optical Sciences Ltd Ireland up to 2007. A company dedicated to providing Cleanroom Environmental Monitoring solutions. Qualified as an Engineering Technologist [ Australian Institute of Engineers (2007)]. Has been working with Kenelec Scientific since 2007 overseeing all Facility Monitoring Projects
and is a current signatory for NATA.

Jason has over 15 years experience with Cleanroom Monitoring and Monitoring Equipment. Designed and installed many Environmental Monitoring Systems to comply with regulatory standards and has worked with main manufacturers of Particle Counters for many years.

 

Topic: Environmental monitoring in compounding clean rooms

The presentation covers aspects of environmental monitoring including overview of present standards, regulatory requirements, large and small volume compounding, meting TGA expectations, what is an EMS and how can it improve product quality, what do I do with the data? Can a portable system work? If you’re a small healthcare establishment what do I need to know about environmental monitoring? Recent recalls due to improper monitoring. New technologies in rapid microbial detection in real-time and how to implement this technology.

 

 

Genes FX, Australia

Sam Mostafa

About:


Sam Mostafa is the Clinical Pharmacist at GenesFX Health. Sam’s expertise in drug metabolism and quality use of medicines provides clinical interpretation and reporting of pharmacogenomic test results to doctors throughout Australia, and involves him in pharmacogenomic research projects, together with Professor Les Sheffield, at major Victorian Hospitals.

In this exciting new area of personalized medicine, he provides continuing education for doctors as part of the GenesFX team, and has presented on the clinical use of pharmacogenomics at recent events such as: The Mental Health Services 20th Annual Conference in Sydney; the GPCE Conference in Melbourne; and The Future of the PBS Conference in Sydney 2011.

 

Topic: Pharmacogenomics – A new innovation in pharmacy clinical practice

Pharmacogenomics is transforming the practice of medicine by providing clinicians with the tools to predict whether a medication will be effective and safe for a particular person and to help prevent adverse drug reactions. There are now gene tests available to determine the most accurate dose for the individual patient. It is envisaged that compounding pharmacists are expected to provide specific dosages for patients following this type of testing. This testing is currently available in Australia covering approximately 50% of drugs in clinical practice and the list is growing.

Currently medications are prescribed on a "one size fits all" approach, but they don't work the same way for everyone. It can be difficult to predict who will benefit from a medication, who will not respond at all, and who will experience negative side effects. Of these patients, some will respond as expected to the treatment without side-effects, some will have minimal or sub therapeutic response and some will experience significant side-effects that would result in ceasing of the medication.

The one size fits all approach to prescribing assumes that all patients process medications in the same way. In fact pharmacogenomics shows the significant variability amongst individuals in the general population and can identify how different individuals will respond to the same drug.

Pharmacogenomics has the clear potential to improve patient safety and quality of care by reducing adverse drug events and improving the effectiveness of pharmaceuticals by prescribing the right drug and dose the first time.

 

 

Australian Custom Pharmaceuticals

Daryll Knowles BPharm, MPS, AFACP, FPPF, ASCC, FAARM, OPM (Harvard)

About:


Daryll Knowles is the owner of Australian Custom Pharmaceuticals, Australia’s largest compounding-only pharmacy. ACP has produced over 20,000,000 doses of compounded medicines since opening in 2003. Daryll graduated Sydney University with a Bachelor of Pharmacy (1980) and now has over 30 years compounding experience. He is also a graduate of PCCA Aseptic Techniques and Primary Training Course (Houston, Texas). He is a fellow of A5M Anti-Ageing, Regenerative and Functional Medicine. Daryll is also a graduate of Harvard Business School (HBS) Owner/President Management Program (OPM).

He was a retail pharmacist for 25 years, owning 7 pharmacies. During this time he was awarded AIPM Pharmacy Manager of the Year in 1995.

Daryll is also the CEO and chairman of the board of NxGen Group Pty. Ltd. and Board member of Australasian Academy of Anti-Ageing Medicine (A5M) and Allmedic Pty. Ltd. Daryll’s current industry affiliations include: Member of the Pharmaceutical Society of Australia (M.P.S.), Associate Fellow of the Australian College of Pharmacy (A.F.A.C.P.), Life Fellow of the Pharmacy Practice Foundation (F.P.P.F.), member of the Australian Society of Cosmetic Chemists (A.S.C.C.) and a Fellow in Anti-Ageing and Regenerative Medicine (F.A.A.R.M.).

He provides extensive training and lectures to graduate pharmacists as a preceptor for Sydney University and University of Queensland Master of Pharmacy & Bachelor of Pharmacy Programs. Daryll also lectures for the A5M Fellowship in Anti-Ageing, Regenerative and Functional Medicine and Curtin University.

 

Topic: Establishing a compounding business strategy, planning and marketing

Abstract to be added shortly.

 

 

Broadbeach Pharmacy

Jack Hammond M.Pharm., B.Pharm Scl. 

About:


Jack completed his Masters degree at Griffith University on the Gold Coast and went on to work in a compounding pharmacy as a pre-reg pharmacist. After discovering compounding at University his passion for it grew stronger once he moved to Broadbeach to manage Broadbeach Pharmacy in 2007. In 2009, he purchased Broadbeach Compounding Pharmacy and continued to grow his business with his marketing techniques and customer service.

Jack has worked in a compounding pharmacy for over 7 years and has completed both the PCCA Pharmacist training course and the PCCA Veterinary Compounding course. He has a passion for Veterinary compounding and Nutritional Compounding for Autism and other mental conditions.

 

Topic: Budgeting and pricing structure for a compounding pharmacy

Abstract to be added shortly.

 

 

Queensland Health

Sue Turner

About:


Biography to be added shortly.

 

Topic: This worked for me — aseptics

Abstract to be added shortly.

 

 

NxGen

Michael Tattersall

About:


Michael Tattersall graduated from the University of Western Sydney with a Diploma in Business in 2000. Michael is a licensed real estate agent with an extensive history of management and training.

Mr Tattersall was a Specialist Civilian Contractor with the Royal Australian Navy specializing in mechanical engineering. During this period, he was part of a team that provided a turnkey installation of IMASAT satellite communications system.

Michael has had extensive management experience as a foreman in an engineering organisation and a sales & rentals manager for one of the world’s largest providers of satellite communication systems. Further, Mr Tattersall acquired a long haul transport company in 1994 and tripled its revenue over 5 years, before selling out in 1999.

He also currently holds directorships on various boards and is a member of the Australian Institute of Company Directors.

Topic: Building and constructing a compounding area

Abstract to be added shortly.